Back to Search Start Over

Altered muscle membrane potential and redox status differentiates two subgroups of patients with chronic fatigue syndrome.

Authors :
Jammes Y
Adjriou N
Kipson N
Criado C
Charpin C
Rebaudet S
Stavris C
Guieu R
Fenouillet E
Retornaz F
Source :
Journal of translational medicine [J Transl Med] 2020 Apr 19; Vol. 18 (1), pp. 173. Date of Electronic Publication: 2020 Apr 19.
Publication Year :
2020

Abstract

Background: In myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), altered membrane excitability often occurs in exercising muscles demonstrating muscle dysfunction regardless of any psychiatric disorder. Increased oxidative stress is also present in many ME/CFS patients and could affect the membrane excitability of resting muscles.<br />Methods: Seventy-two patients were examined at rest, during an incremental cycling exercise and during a 10-min post-exercise recovery period. All patients had at least four criteria leading to a diagnosis of ME/CFS. To explore muscle membrane excitability, M-waves were recorded during exercise (rectus femoris (RF) muscle) and at rest (flexor digitorum longus (FDL) muscle). Two plasma markers of oxidative stress (thiobarbituric acid reactive substance (TBARS) and oxidation-reduction potential (ORP)) were measured. Plasma potassium (K <superscript>+</superscript> ) concentration was also measured at rest and at the end of exercise to explore K <superscript>+</superscript> outflow.<br />Results: Thirty-nine patients had marked M-wave alterations in both the RF and FDL muscles during and after exercise while the resting values of plasma TBARS and ORP were increased and exercise-induced K <superscript>+</superscript> outflow was decreased. In contrast, 33 other patients with a diagnosis of ME/CFS had no M-wave alterations and had lower baseline levels of TBARS and ORP. M-wave changes were inversely proportional to TBARS and ORP levels.<br />Conclusions: Resting muscles of ME/CFS patients have altered muscle membrane excitability. However, our data reveal heterogeneity in some major biomarkers in ME/CFS patients. Measurement of ORP may help to improve the diagnosis of ME/CFS. Trial registration Ethics Committee "Ouest II" of Angers (May 17, 2019) RCB ID: number 2019-A00611-56.

Details

Language :
English
ISSN :
1479-5876
Volume :
18
Issue :
1
Database :
MEDLINE
Journal :
Journal of translational medicine
Publication Type :
Academic Journal
Accession number :
32306967
Full Text :
https://doi.org/10.1186/s12967-020-02341-9